Dr Antonio D'Alessio

Dr Antonio D'Alessio is a highly dedicated Consultant Medical Oncologist who specialises in the comprehensive care and management of hepatobiliary malignancies. Driven by a commitment to delivering compassionate, evidence-based care, he collaborates closely with multidisciplinary clinical teams to design personalised treatment plans tailored to each patient's individual needs. Dr D'Alessio is widely recognised for his clinical expertise in treating primary liver cancers, including hepatocellular carcinoma and cholangiocarcinoma.

Dr D'Alessio earned his medical degree from the University of Naples before completing advanced specialty training in Medical Oncology across Italy and the United Kingdom. Demonstrating a firm commitment to academic advancement, he subsequently completed a PhD at Imperial College London, where his research examined response mechanisms and therapeutic outcomes associated with immunotherapy in liver cancer. He maintains active professional memberships with leading international bodies, including the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the European Association for the Study of the Liver (EASL), the International Liver Cancer Association (ILCA), the American Association for Cancer Research (AACR), and the British Association for Cancer Research (BACR).

In clinical practice, Dr D'Alessio focuses on innovative systemic therapies, particularly the application of novel immunotherapies and immune checkpoint inhibitors. His translational research endeavours centre on evaluating neoadjuvant immunotherapy protocols administered prior to surgery, alongside identifying predictive biomarkers of treatment response. Through his ongoing involvement in early-phase clinical trials, Dr D'Alessio remains at the forefront of oncological developments, striving to improve therapeutic outcomes and quality of life for his patients.